Peptides against Low Density Lipoprotein (LDL) Aggregation Inhibit Intracellular Cholesteryl Ester Loading and Proliferation of Pancreatic Tumor Cells
Por:
Benitez-Amaro, A, Martinez-Bosch, N, Manero-Ruperez, N, Claudi, L, Lhoest, MTL, Soler, M, Ros-Blanco, L, Navarro, P, Llorente-Cortes, V
Publicada:
1 feb 2022
Resumen:
Simple Summary Dyslipidemia is a modifiable risk factor for pancreatic ductal adenocarcinoma (PDAC), one of the most lethal cancers. A key component of dyslipidemia is a high level of small and dense low-density lipoproteins (LDLs). These LDLs have a high probability to be entrapped and modified (aggregated) in the extracellular matrix (ECM), becoming a source of cholesterol for tumor cells. However, the effect of aggregated LDLs on tumor progression has been unexplored. The aim of this work was to determine the effect of modified LDLs on intracellular cholesteryl ester/free cholesterol ratio (CE/FC) and cancer cell growth, and the efficacy of peptides designed to inhibit LDL aggregation on these processes. Our results show that aggregated LDL upregulates the intracellular CE/FC ratio and cell growth in pancreatic cancer and that these upregulatory effects were blocked by peptides against LDL aggregation. We propose that anti-LDL aggregation peptides deserve to be further investigated as anti-tumoral strategies. Dyslipidemia, metabolic disorders and/or obesity are postulated as risk factors for pancreatic ductal adenocarcinoma (PDAC). The majority of patients with these metabolic alterations have low density lipoproteins (LDLs) with increased susceptibility to become aggregated in the extracellular matrix (ECM). LDL aggregation can be efficiently inhibited by low-density lipoprotein receptor-related protein 1 (LRP1)-based peptides. The objectives of this work were: (i) to determine if aggregated LDLs affect the intracellular cholesteryl ester (CE)/free cholesterol (FC) ratio and/or the tumor pancreatic cell proliferation, using sphingomyelinase-modified LDL particles (Aggregated LDL, AgLDL); and (ii) to test whether LRP1-based peptides, highly efficient against LDL aggregation, can interfere in these processes. For this, we exposed human pancreatic cancer cell lines (PANC-1, RWP-1 and Capan-1) to native (nLDL) or AgLDLs in the absence or presence of LRP1-based peptides (DP3) or irrelevant peptides (IP321). Results of thin-layer chromatography (TLC) following lipid extraction indicate that AgLDLs induce a higher intracellular CE/FC ratio than nLDL, and that DP3 but not IP321 counteracts this effect. AgLDLs also increase PANC-1 cell proliferation, which is inhibited by the DP3 peptide. Our results indicate that AgLDL-induced intracellular CE accumulation plays a crucial role in the proliferation of pancreatic tumor cell lines. Peptides with anti-LDL aggregation properties may thus exhibit anti-tumor effects.
Filiaciones:
Benitez-Amaro, A:
CSIC, Inst Biomed Res Barcelona IIBB, Barcelona 08036, Spain
Biomed Res Inst St Pau IIB St Pau, Barcelona 08025, Spain
Martinez-Bosch, N:
Hosp Mar Med Res Inst IMIM, Canc Res Program, Unidad Asociada IIBB CSIC, Barcelona 08003, Spain
Manero-Ruperez, N:
Hosp Mar Med Res Inst IMIM, Canc Res Program, Unidad Asociada IIBB CSIC, Barcelona 08003, Spain
Claudi, L:
CSIC, Inst Biomed Res Barcelona IIBB, Barcelona 08036, Spain
Biomed Res Inst St Pau IIB St Pau, Barcelona 08025, Spain
Lhoest, MTL:
CSIC, Inst Biomed Res Barcelona IIBB, Barcelona 08036, Spain
Biomed Res Inst St Pau IIB St Pau, Barcelona 08025, Spain
Soler, M:
Biomed Res Inst St Pau IIB St Pau, Barcelona 08025, Spain
Ros-Blanco, L:
Biomed Res Inst St Pau IIB St Pau, Barcelona 08025, Spain
Navarro, P:
CSIC, Inst Biomed Res Barcelona IIBB, Barcelona 08036, Spain
Hosp Mar Med Res Inst IMIM, Canc Res Program, Unidad Asociada IIBB CSIC, Barcelona 08003, Spain
August Pi Sunyer Biomed Res Inst IDIBAPS, Barcelona 08036, Spain
Llorente-Cortes, V:
CSIC, Inst Biomed Res Barcelona IIBB, Barcelona 08036, Spain
Biomed Res Inst St Pau IIB St Pau, Barcelona 08025, Spain
Inst Hlth Carlos III, CIBERCV, Madrid 28029, Spain
Green Published, gold, Gold, Green
|